We found that high expression of GLIS2 target genes enables the segregation of claudin-low tumors from other breast tumors in a manner similar to the Prat et al. (37) reference panel of genes used to mark claudin-low cancers (Fig. 6D). Here, GLIS2 is linked to breast neoplasm.